Cardiac fibrosis plays an important role in cardiac remodeling after myocardial infarction (MI). The molecular mechanisms that promote cardiac fibrosis after MI are well studied; however, the mechanisms by which the progression of cardiac fibrosis becomes attenuated after MI remain poorly understood. Recent reports show the role of cellular senescence in limiting tissue fibrosis. In the present study, we tested whether cellular senescence of cardiac fibroblasts (CFs) plays a role in attenuating the progression of cardiac fibrosis after MI. We found that the number of γH2AX-positive CFs increased up to day 7, whereas the number of proliferating CFs peaked at day 4 after MI. Senescent CFs were also observed at day 7, suggesting that attenuation of CF proliferation occurred simultaneously with the activation of the DNA damage response (DDR) system and the appearance of senescent CFs. We next cultured senescent CFs with non-senescent CFs and showed that senescent CFs suppressed proliferation of the surrounding non-senescent CFs in a juxtacrine manner. We also found that the blockade of DDR by Atm gene deletion sustained the proliferation of CFs and exacerbated the cardiac fibrosis at the early stage after MI. Our results indicate the role of DDR activation and cellular senescence in limiting cardiac fibrosis after MI. Regulation of cellular senescence in CFs may become one of the therapeutic strategies for preventing cardiac remodeling after MI.
M yocardial infarction (MI) is one of the major causes of chronic heart failure (CHF), which affects 26 million people worldwide. 1) Following MI, cardiac fibroblasts (CFs) in the infarct area become activated, proliferate, and produce an extracellular matrix to replace the necrotic tissue with fibrotic tissue. 2, 3) These processes are termed cardiac fibrosis. Cardiac fibrosis is necessary for maintaining tissue integrity after MI, but excess cardiac fibrosis leads to adverse cardiac remodeling and CHF. 4) Although the mechanism by which CFs are activated and start proliferation is well studied, [5] [6] [7] how activated CFs return to a non-proliferative state after MI remains poorly understood.
Upon DNA damage, DNA damage response (DDR) signaling becomes activated to stop the cell cycle and repair damaged DNA. Ataxia telangiectasia mutated (ATM) is one of the key protein kinases that transduces the DDR signal to the effector proteins through phosphorylating its substrates, such as histone variant H2AX and tumor suppressor p53. 8, 9) When the damage to the DNA is too severe to be repaired, DDR becomes persistent and triggers apoptotic cell death or stops the cell cycle permanently by inducing cellular senescence. 10, 11) Recent reports suggest that activated hepatic fibroblasts become senescent after fibrotic liver injury and play a role in limiting tissue fibrosis both in a cell autonomous and a non-cell autonomous manner. 12, 13) In the present study, we investigated the role of CF senescence in cardiac fibrosis after MI. We show that DDR is activated, and cellular senescence takes place in CFs after MI. We also show in vitro and in vivo evidence that senescent CFs suppress proliferation of surrounding SHIBAMOTO, ET AL non-senescent CFs in a cell-cell, contact-dependent manner and play a role in attenuating the progression of cardiac fibrosis. Regulation of cellular senescence in CFs may become one of the therapeutic strategies for limiting cardiac fibrosis and preventing cardiac remodeling after MI.
Methods
Animal: C57BL/6J mice and fetal ICR mice were from CLEA Japan, Inc. Atm +/− mice 14) were from Jackson Laboratory (stock#008536, stock name: B6.129S6-Atm tm1Awb/J ). The Atm wild-type (WT) and mutant alleles were detected by genotyping PCR according to the protocol from Jackson Laboratory. C57BL/6-Tg (CAG-EGFP) C14-Y01-FM 131Osb mice, 15) in which EGFP expression was under the control of the CAG promoter, were from RIKEN Bioresource Center (BRC00267). The PCR primers are shown in the Table. All experiments were approved by the Institutional Animal Care and Use Committee of Osaka University (22-056) and carried out in accordance with its guidelines.
Myocardial infarction model:
To generate a mouse model of MI, 8-to 12-week old male mice were anesthetized with 2.8% isoflurane inhalation under mechanical ventilation. The heart was exposed by a left thoracotomy followed by the ligation of left anterior descending coronary artery (LAD) using 8-0 nylon suture. 16) Myocardial ischemia was confirmed by the changes in the color of heart tissue and the motion of left ventricular (LV) wall. Transthoracic echocardiography was performed with Vevo 770 imaging system (Visualsonics, Inc.). M-mode echocardiographic image in a longitudinal view was used to measure the LV function and size. Immunofluorescence: For immunofluorescent staining, the hearts were excised and immediately embedded in Tissue-Tek OCT compound (Sakura Finetek Japan). Cryostat sections at 4 μm were fixed in acetone, washed in PBS, and incubated in either 5% normal donkey serum (Sigma) or Mouse on Mouse basic kit (Vector Laboratories) to block nonspecific binding. Sections were then incubated with primary antibodies overnight. After washing with PBS, samples were incubated with fluorochromeconjugated secondary antibodies for 1 hour, and the nuclei were counterstained with TO-PRO-3 iodide 642/661 (1: 200) (Thermo Fisher Scientific). For the staining of cultured cells, cells were fixed with 4% paraformaldehyde (PFA) and permeabilized with 0.25% Triton-X100. Cells were then incubated with primary and secondary antibodies as described above. Images were obtained by the confocal laser scanning microscopy LSM700 (Carl Zeiss), FSX100 (Olympus) or IN Cell Analyzer 6000 (GE Healthcare). The infarct area was distinguished visually. The border area was defined as the region within 100 μm from the infarct area. The primary antibodies used were as follows: rabbit polyclonal anti-H2AX (phospho-Ser139) (1:500) (ab2893, Abcam), chicken polyclonal antivimentin (1:500) (ab24525, Abcam), mouse monoclonal anti-Histone H3 (phospho-Ser10) (1:500) (ab14955, Abcam), rabbit polyclonal anti-green fluorescent protein (GFP) (1:200) (ab6556, Abcam) and mouse monoclonal anti-alpha smooth muscle actin (1:250) (ab7817, Abcam). The secondary antibodies used were as follows: anti-rabbit Flow cytometry, FACS: Cell samples were prepared by sequentially digesting the minced heart tissue with dispase II (Wako) in PBS, followed with collagenase type 1 (Wako) in PBS containing 4% fetal bovine serum (FBS, Biowest), 0.9 mM CaCl2 and 0.33 mM MgCl2. Cells were then pelleted, suspended in PBS containing 4% FBS, and filtered through 40 μm cell strainer (BD Falcon). 17) Nonspecific binding was blocked using anti-mouse CD16/32 Antibody (1:100) (101301, BioLegend). For fluorescentactivated cell sorting (FACS), cells were stained with antimouse CD31-BV421 (1:100) (562939, BD Biosciences), anti-mouse CD45-APC (1:50) (559864, BD Biosciences), anti-mouse Thy1-FITC (1:50) (553013, BD Biosciences), and anti-mouse PDGFRα-PE (1:80) (135905, Biolegend). 7-aminoactinomysin D (1:100) (Thermo Fisher Scientific) was used for dead cell exclusion. Cell sorting was performed by BD FACSAria II. For flow cytometric analysis of γH2AX, cells were fixed and permeabilized by using eBioscience Intracellular Fixation & Permeabilization Buffer Set (eBioscience) according to the manufacturer's instructions. Cells were then stained with anti-mouse CD 31-BV421 (1:100), anti-mouse CD45-APC (1:50), and anti-mouse H2AX (phospho-Ser139)-FITC (1 μL/1 × 106 cells) (613403, Biolegend), and counterstained with Fixable Viability Stain 510 (1:1,000) (BD Biosciences) for dead cell exclusion. Cells were analyzed by BD FACSAria II and Flo Jo software (Tree Star). TUNEL assay: TdT-mediated dUTP nick end labeling (TUNEL) assay was performed by using in situ Apoptosis Detection Kit (Takara Bio Inc.) according to the manufacturer's instructions. Briefly, cryostat sections at 4 μm or FIBROBLAST SENESCENCE LIMITS CARDIAC FIBROSIS cells cultured on gelatin-coated coverslips were fixed with 3% PFA, permeabilized and incubated with TdT enzyme, including FITC-conjugated dUTP for 60 minutes at 37 . Nuclei were counterstained with TO-PRO-3 iodide 642/ 661 (1:200). RNA analysis: Total RNA was extracted using the TRIzol Reagent (Life Technologies) or the PureLink RNA Mini Kit (Life Technologies) and treated with DNase using TURBO DNA-free Kit (Invitrogen) or PureLink DNase Set (Invitrogen), respectively. Reverse transcription was performed by using the SuperScript VILO cDNA Synthesis Kit (Invitrogen). Quantitative real-time PCR (qPCR) was performed by using THUNDERBIRD Probe qPCR Mix (Toyobo) with the target-specific primers and the matching probes designed by the Universal Probe Library System (Roche Applied Science). Relative expression levels of the target genes were calculated by comparative Ct method using 28S ribosomal RNA as an internal control. Isolation and culture of cardiac fibroblasts: CFs were isolated from the heart of mice embryo around embryonic day 15. Since few CFs can be obtained from a single embryo, we pooled the CFs from approximately 60 embryos. The heart was quickly removed and digested in Ca
2+
-free Hank's balanced salt solution (Cellgro) containing 100 μg/ mL trypsin (TRLSNK, Worthington Biochemical Corp.) and 70 U/mL collagenase (CLSPANK, Worthington Biochemical Corp.). Cells were then plated onto a tissue culture plate for 1 hour, and the supernatant containing cardiomyocytes was removed. Attached cells, containing mainly CFs, were cultured in Medium 199 (M 199) (Cellgro) containing 15% FBS for an additional 24 hours, and the cells were thereafter cultured in Dulbecco's modified Eagle medium (Wako) containing 10% FBS, 100 U/mL penicillin and 100 μg/mL streptomycin. We used 24-Well ThinCert Cell Culture Inserts (662630, Greiner) for Boyden chamber system. Cell proliferation assay: Proliferating CFs were labeled by culturing them in the presence of 5-bromo-2'-deoxyuridine (BrdU) or 5-ethynyl-2'-deoxyuridine (EdU) (10 μM) for 24 hours. BrdU-labeled cells were denatured with 2M HCl for 10 minutes and incubated with rat monoclonal anti-BrdU (1:200) (ab6326, Abcam) followed by anti-rat IgG-Alexa 488 (1:200) (A-21208, Thermo Fisher Scientific). EdU-labeled cells were stained according to the manufacturer's protocol (Click-it Plus EdU Alexa Fluoro 594 Imaging Kit, Thermo Fisher Scientific). Nuclei were counterstained with TO-PRO-3 iodide 642/661 (1: 200) or NucBlue Live ReadyProbes Reagent (Thermo Fisher Scientific). Western blot: Cultured CFs were homogenized and lysed with RIPA buffer with protease and phosphatase inhibitor cocktails for 30 minutes on ice. The cell lysate was centrifuged at 15,000g for 20 minutes and the supernatant was used as whole-cell extract. For nuclear fractionation, heart tissue was homogenized and lysed in hypotonic buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.1 mM DTT, and 0.05% NP-40, pH 7.9) with protease and phosphatase inhibitor cocktails (respectively, Roche) for 10 minutes on ice. Nuclei were pelleted by centrifugation at 800g for 10 minutes and lysed in RIPA buffer to obtain nuclear extracts. The protein samples were subjected to SDS-PAGE and transferred to nitrocellulose membranes (GE Healthcare). After blocking with 5% skim milk, the membranes were incubated with mouse monoclonal anti-ATM antibody (1:10,000) (ab59541, Abcam), and rabbit monoclonal anti-GAPDH (1:10,000) (#2118, Cell Signaling Technology) or rabbit polyclonal anti-Histone H3 antibody (1: 5,000) (H0164, Sigma), followed by horseradish peroxidase-conjugated anti-mouse or anti-rabbit IgG (715-035-151 or 711-035-152, respectively, Jackson ImmunoResearch). The immunoreactive signal was detected with ECL Plus Western Blotting Detection System (GE Healthcare), and the images were obtained by ImageQuant LAS4000 (GE Healthcare). Gene knockdown: For gene silencing, cultured CFs were transfected with pre-designed siRNAs against Atm (s62962, Ambion) using Lipofectamine RNAiMAX Transfection Reagent (13778150, Invitrogen) according to the manufacturer's instructions. A negative control duplex (Medium GC Duplex, 12935300, Invitrogen) was used as control. Oligonucleotide sequences of the siRNA against Atm were 5'-GGCUGUCAACUUCCGAAAAtt -3' (sense) and 5'-UUUUCGGAAGUUGACAGCCag -3' (antisense). Histochemical staining: For histochemical staining, cryostat sections at 8 μm were fixed in 2% PFA for three hours at 4 and stained with hematoxylin and eosin (MUTO PURE CHEMICALS CO., LTD.), or with Trichrome Stain (Masson) Kit (Sigma) and Weigert's iron hematoxylin solution (Sigma), according to manufacturer's protocol. The LV %fibrotic area was calculated as the ratio of the fibrotic area to the total area at the papillary muscle level and apex level using ImageJ software (National Institutes of Health, Bethesda, MD). Senescenceassociated beta-galactosidase (SA-β-gal) staining was performed using Senescence Detection Kit (Abcam). For the staining of heart tissue, cryostat sections at 8 μm were fixed in 2% PFA for 3 hours at 4 and stained for 48 hours at 37 . The cell nuclei were stained by Nuclear Fast Red (Labvision). For the staining of cultured cells, cells were fixed in 2% PFA for 15 minutes, and stained for 16 hours at 37 . The cell nuclei were stained by NucBlue Live ReadyProbes Reagent. Images were obtained by BZ-9000 (Keyence). Statistical analysis: All data are presented as mean ± s.e.m. Two-group comparison was performed by unpaired two-tailed Student's t-test or Mann-Whitney U-test. Multiple group comparison was performed by Dunnett test and Tukey-Kramer HSD test. Survival after MI operation was analyzed by Kaplan-Meier method and a two-group comparison was performed by Wilcoxon test. Statistical analyses were performed with JMP Pro 13.2.1 (SAS Institute Inc). Significant differences were defined as P < 0.05.
Results
Activation of DDR and cellular senescence in cardiac fibroblasts after MI: To examine the role of DDR activation and cellular senescence in cardiac fibrosis after MI, we first analyzed the time course of DDR activation and the markers of cellular senescence in CFs. We found that the number of CFs positive for phosphorylated H2AX (γH 2AX), a marker that labels the cells with active DDR, in-creased from day 3 up to day 7 in the border and infarct area after MI ( Figure 1A, B) . Flow cytometric analysis also revealed that the fluorescence intensity of γH2AX in CFs increased 1.5-fold at day 7 after MI ( Figure 1C, D Figure 1E ). A number of CFs positive for senescence-associated betagalactosidase (SA-β-gal), which is the most wellestablished marker for cellular senescence, 18) were also observed in the border and the infarct area at day 7 after MI ( Figure 1F ). We then analyzed the time course of CF proliferation. The number of CFs positive for phosphorylated histone H3 (pHH3), a marker for proliferating cells, also increased up to day 4 but decreased thereafter (Figure 2A,  B) . TUNEL-positive CFs were observed at only low levels and did not increase after MI ( Figure 2C, D) . Our observations show that the activation of DDR in CFs and the appearance of senescent CFs occurred simultaneously with deceleration of CF proliferation suggesting the strong relationship between these processes. Establishment of an in vitro model of stress-induced senescence in CFs: To investigate the role of DDR activation and cellular senescence on the proliferation of CFs, we first established an in vitro model of senescent CFs by ionizing radiation (IR). 19, 20) The number of BrdU-positive CFs significantly decreased at the dose more than 2 Gy ( Figure 3A, B) . The number of γH2AX-positive CFs increased ( Figure 3C , D) and senescent CFs appeared at the dose more than 5 Gy (Figure 3E, F) . There was a statistically significant increase in the number of TUNELpositive CFs at the dose of 10 Gy but not at 5 Gy ( Figure  3G, H) . These results collectively suggest that irradiation at the dose of 5 Gy activates DDR, impairs proliferative capacity, and induces cellular senescence without affecting cellular apoptosis in cultured CFs. Senescent CFs suppressed the proliferation of the surrounding non-senescent CFs: Senescent cells alter the phenotype of surrounding non-senescent cells via paracrine or juxtacrine mechanisms. 21, 22) We therefore examined the paracrine and/or juxtacrine effects of senescent CFs on the proliferative capacity of non-senescent CFs. We first examined the paracrine effect by using Boyden chamber system. 23) We cultured either irradiated or nonirradiated CFs in the upper chamber and co-cultured with CFs in the lower chamber for 72 hours. The proliferative capacity of the CFs in the lower chamber was assessed by incorporation of EdU for the last 24 hours ( Figure 4A ). Irradiation to the CFs in the upper chamber did not affect the percentage of EdU-positive CFs in the lower chamber, suggesting that senescent CFs do not affect the proliferative capacity of non-senescent CFs in a paracrine manner ( Figure 4B, C) . We next examined the juxtacrine effect of senescent CFs by culturing the non-labeled CFs, either irradiated or non-irradiated, with GFP-labeled CFs in a mixed culture and assessed the proliferative capacity of GFP-labeled CFs ( Figure 5A ). In this case, irradiated, senescent CFs significantly attenuated the proliferation of GFP-labeled CFs ( Figure 5B, C) suggesting that senescent CFs suppress the proliferation of surrounding CFs in a juxtacrine manner ( Figure 5D ).
We also examined the involvement of ATM in DDR, cellular senescence and the juxtacrine effect of senescent cells on CF proliferation. 24, 25) Knockdown of Atm gene by siRNA attenuated the activation of DDR ( Figure 6A ) and the appearance of senescent cells after irradiation ( Figure  6B ). Moreover, irradiated CFs with Atm gene knockdown showed a less suppressive effect on the proliferation of surrounding CFs (Figure 6C, D) , suggesting that the juxtacrine effect of senescent CFs on the proliferation of surrounding non-senescent CFs is also mediated by ATM. Cardiac fibrosis was exacerbated in ATM heterozygous mice: We finally investigated the role of ATM in cardiac fibrosis after MI. Heterozygous deletion of Atm inhibits persistent DDR activation in heart failure model mice. 26) We therefore induced MI in ATM heterozygous mice (Atm +/− mice) and observed the effect of Atm gene deletion on CF proliferation, cellular senescence, and cardiac fibrosis after MI. Decreased expression of ATM was confirmed in the heart tissue and CFs of Atm +/− mice at both mRNA and protein level ( Figure 7A, B) . In Atm +/− mice, the number of pHH3-positive proliferating CFs was more observed ( Figure 7C, D) , whereas the number of SA-β-galpositive CFs was less observed ( Figure 7E ) at day 7 after MI compared with wild-type (WT) mice. Masson's trichrome staining showed that the fibrotic area at both mid and apical level of the heart was significantly increased at day 7 after MI ( Figure 8A , B). It should be noted that the effect of heterozygous Atm gene deletion on cardiac fibrosis became comparable with WT mice at day 28 after MI ( Figure 8A, B) . In addition, LV function (Figure 8C) , the signs of heart failure ( Figure 8D ) and the mortality ( Figure 8E ) were also comparable between Atm +/− and WT. These results suggest that ATM is involved in CF proliferation and cardiac fibrosis only at the early phase after MI, which may not affect the long-term outcome of MI, at least in mice.
Discussion
Excess activation and proliferation of CFs after MI lead to adverse cardiac remodeling and CHF. 2, 3) On the other hand, proper activation and proliferation of CFs after MI are required to maintain the strength of the myocardium and prevent cardiac rupture. 4) In a mouse model of MI, activation and proliferation of CFs are observed soon after coronary artery ligation. 3) In the present study, we found that the activation of DDR and the induction of cellular senescence occurred simultaneously in these proliferating CFs at the subsequent stage after coronary artery ligation. We also showed that the blockade of DDR effector ATM liberated CFs from cellular senescence and exacerbated cardiac fibrosis after MI, indicating that DDR activation and cellular senescence play critical roles in suppressing the proliferation of CFs. Recent reports show the involvement of cellular senescence in regulation of tissue fibrosis. 12, 13, 27) Upon fibrotic liver damage, hepatic stellate cells, resident fibroblasts in the liver tissue, become activated and proliferate to form liver fibrosis. Some of the activated stellate cells become senescent thereafter and senescent stellate cells in turn limit liver fibrosis.
12) A similar phenomenon is also reported in the wound healing process after skin damage. 27) Taken together, senescence of fibroblasts seems to play a key role in tissue fibrosis through regulating the activation and proliferation of fibroblasts.
Cellular senescence is considered one of the antitumor mechanisms by which cells with extensive DNA damage no longer proliferate.
10) Senescent cells are not only stunned, non-proliferating cells but also affect their surrounding microenvironments through changing their gene expression patterns. This characteristic change in the gene expression pattern is called senescent-associated secretory phenotype (SASP). Through acquisition of SASP, senescent cells modify the disease processes by changing the cell-cell adhesion, secreting various kinds of cytokines such as IL-1α, IL-6, IL-8, and transforming growth factor (TGF)-β. 28) In the present study, we examined the noncell autonomous effect of senescent CFs using Boyden chamber system and co-culture system. Interestingly, senescent CFs suppressed the proliferation of non-senescent CFs only when they were co-cultured, suggesting that contact-dependent mechanism is involved in the non-cell autonomous effect of senescent CFs. The precise mechanism by which senescent CFs suppress the proliferation of surrounding cells needs further investigation in the future study.
In the present study, we showed the detrimental effect of Atm gene deletion on cardiac fibrosis at the acute phase but not on the cardiac function and cardiac fibrosis at the chronic phase. This result is in clear contrast with the report from Daniel et al. showing that ATM deficiency exacerbates cardiac dysfunction as well as cardiac fibrosis after MI even at the chronic phase. 29) Given that the mortality rate was higher (44%-61%) in the previous report compared to the present study (˜80%), it is suggested that the difference in the infarct size may explain the discrepancy between the results in both studies.
From clinical perspectives, adequate induction of cellular senescence in CFs may become a novel therapeutic strategy for preventing adverse cardiac remodeling after MI. Suppression of premature senescence in CFs by ge- netic ablation of p53 and p16
INK4
, which play a key role in cellular senescence, leads to aggravated cardiac fibrosis in pressure overload-induced heart failure model mice. 30) In contrast, induction of premature senescence in CFs by gene transfer of CCN family member 1 27, 30) limits cardiac fibrosis and improves cardiac function. In the present study, we also found that the suppression of DDR and premature senescence by Atm gene deletion exacerbated cardiac fibrosis after MI. A report from other groups also show that administration of RITA (reactivation of p53 and induction of tumor cell apoptosis), a stabilizer of a major DDR effector protein p53, attenuates cardiac fibrosis in a mouse model of ischemia-reperfusion cardiac injury. 31) Taken together, these findings suggest that cellular senescence in CFs is necessary and sufficient to limit cardiac fibrosis, irrespective of the etiology of heart failure, and SHIBAMOTO, ET AL Figure 6 . ATM mediates the juxtacrine effect of senescent cardiac fibroblasts on the proliferation of surrounding non-senescent cardiac fibroblasts. A: After siRNA transfection, cultured CFs were irradiated at 5 Gy and immunostained for γH2AX, α-SMA and TO-PRO-3. The percentage of γH2AX + cells was calculated (n = 4 each). The cells with more than 3 foci were defined as γH2AX + . (Control). B: Irradiated CFs were stained with senescence-associated beta-galactosidase (SA-β-gal). The percentage of cells stained in blue was calculated (n = 5 each). C, D: Non-labeled CFs were transfected with siR-NA against Atm before irradiation and mixed-cultured as described in Figure 5A . Representative images of the stained CFs stained with EdU (red), GFP (green) and TO-PRO-3 (blue) (C, scale bar, 100 μm). Arrowheads indicate EdU + GFP + cells and arrows indicate EdU + GFP − cells. The fraction of EdU + cells within GFP + cells were calculated (D, n = 6 each). Statistical significance was determined by Tukey-Kramer HSD test. †P < 0.01, † †P < 0.0001 versus negative control (Control). N.S indicates not significant. Column and error bars show mean and s.e.m., respectively. Figure 7 . Cardiac fibroblast remained proliferative after myocardial infarction in ATM heterozygous mice. A: The expression levels of Atm in the whole heart tissue (left panel, n = 4 each) and sorted cardiac fibroblasts (right panel, WT; n = 4, Atm +/− ; n = 6) were measured by quantitative real-time PCR. B: The expression level of nuclear ATM protein was assessed by western blotting. Histone H3 was used as loading control. Statistical significance was determined by Student's t-test. †P < 0.01 versus WT. Column and error bars show mean and s.e.m., respectively. C, D: The sections of heart tissue from Sham-and MI-operated WT and Atm +/− mice were stained for phosphorylated Histone H3 (pHH3, green), vimentin (red), and TO-PRO-3 (blue) at day 7 after MI. Arrowheads indicate pHH3 + vimentin + cells. Representative images (C, scale bar, 100 μm). The number of pHH3 + vimentin + cells in the border and infarct area was counted (D, sham; n = 3 each, post-MI day 7; n = 7-8). (E) The sections of heart tissue were stained with senescenceassociated beta-galactosidase (SA-β-gal) at day 7 after MI. Arrowheads indicate SA-β-gal positive cells. Scale bar, 25 μm. Statistical significance was determined by Student's t-test. *P < 0.05; †P < 0.01 versus WT mice. N.S indicates not significant. Column and error bars show mean and s.e.m., respectively. Figure 8 . Cardiac fibrosis was exacerbated at the acute phase after myocardial infarction in ATM heterozygous mice. A, B: The sections of heart tissue were stained with Masson's trichrome staining at day 7 and 28 after MI. Representative images (A, scale bar, 1 mm). The percentage of fibrotic area was calculated as the ratio of the fibrotic area to the total cross-sectional area of left ventricle (B, sham; n = 3 each, post-MI day 7; n = 5 each, post-MI day 28; n = 5, 4, respectively). C: The left ventricular (LV) function of MI-operated WT and Atm +/− mice was assessed by echocardiogram at the indicated time points after MI (n = 4 each). LVFS, LV fractional shortening. D: Heart, lung, and body weight of myocardial infarction (MI) -operated WT and Atm +/− mice were weighed at day 7 after MI. The heart weight or lung weight per body weight were calculated (n = 4 each). Statistical significance was determined by Student's t-test. N.S; not significant. Column and error bars show mean and s.e.m., respectively. Statistical significance was determined by Student's t-test for B, C, and D. †P < 0.01 versus WT mice. N.S indicates not significant. Column and error bars show mean and s.e.m., respectively. E: Survival curve of WT and Atm +/− mice after MI operation (n = 37, 31, respectively). Statistical significance was determined by Wilcoxon test. Figure 9 . The proposed mechanism by which senescent CFs limit cardiac fibrosis after myocardial infarction. The number of CFs with active DDR increase after MI. DDR become persistent in some of the CFs, leading to cellular senescence of CFs. Senescent CFs suppress the proliferation of surrounding CFs in a cellcell contact-dependent manner, at least at the acute phase after MI. ATM plays essential role in this process and genetic deletion of ATM exacerbates cardiac fibrosis after MI.
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that the DDR signaling pathway may become a potential therapeutic target for preventing adverse cardiac remodeling. Our results highlight the role of DDR activation and cellular senescence in 'fine-tuning' of the CF proliferation and delivering appropriate cardiac fibrosis after MI (Figure 9) . Given that insufficient activation and proliferation of CFs lead to cardiac rupture, 32) proper timing and the extent for inducing cellular senescence in CFs should be investigated before clinical applications.
